[go: up one dir, main page]

(Q33388853)

English

Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study (English)
Christian Gisselbrecht
Ingo G H Schmidt-Wolf

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit